Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / October 21, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET.

Interested parties may participate in the call by dialing:

(877) 407-6176 (US Toll-Free)

+1 (201) 689-8451 (International)

Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC

Following the live call, a replay will be available in the Investor Relations section of the Company's website at https://www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at https://www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.44
+0.04 (0.02%)
AAPL  274.17
+4.74 (1.76%)
AMD  239.75
-4.22 (-1.73%)
BAC  53.68
+0.26 (0.49%)
GOOG  289.60
-0.99 (-0.34%)
META  622.49
-9.27 (-1.47%)
MSFT  505.07
-0.93 (-0.18%)
NVDA  192.70
-6.35 (-3.19%)
ORCL  231.61
-9.22 (-3.83%)
TSLA  435.60
-9.63 (-2.16%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.